shock (CS) is characterized by a decreased pumping ability of the heart that causes tissue hypoperfusion.
Shock Therapeutics - Products under Investigation by Universities/Institutes
Our study found that simple parameters available in clinical practice are significantly associated with the need for intubation in acute cardiogenic
pulmonary oedema patients treated with continuous positive airway pressure and medical therapy.
Commenting on current treatments for cardiogenic
shock complicating acute myocardial infarction, Dr.
3) and 11 patients had septic shock and five patients had cardiogenic
Excessive production of nitric oxide in cardiogenic
shock is believed to further compromise heart function.
This study reports on the results of the first 100 patients with AMI cardiogenic
shock and implanted with the AB5000 VAD.
We are committed to bringing this novel therapeutic approach to patients with cardiogenic
shock who have not had adequate treatment options to date and we look forward to starting Phase 3 enrollment.
Cardiac Centers Using TandemHeart[R] Reduce Deaths from Cardiogenic
Shock by up to 50% Compared with National Average1
First, we have the resources to complete a global Phase III trial of our lead drug candidate, a first-in-class, mechanism-based treatment for cardiogenic
Mark Anderson, Chief of Cardiac Surgery at Robert Wood Johnson University Hospital in New Brunswick, New Jersey entitled, "Ventricular Assist Device Support for Acute Myocardial Infarction Cardiogenic
Shock: Is Recovery Sustainable?
The patient, Cornelius King, a resident of Cicero, New York, was implanted first with bi-ventricular BVS 5000 and then AB5000 support following an acute myocardial infarction, also known as an AMI or heart attack, with subsequent cardiogenic